Investment
Features
FeesSafety
Academy
More
Pluang+

Compare DigitalOcean Holdings Inc (DOCN) vs Revvity Inc (RVTY) Price & Performance

DigitalOcean Holdings IncTrade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

DigitalOcean Holdings Inc vs Revvity Inc — how do they compare? DigitalOcean Holdings Inc trades at $126.94 (market cap $14.57B), while Revvity Inc trades at $153.89 (market cap $16.98B). The key difference: Revvity Inc is the larger of the two by market cap, and Revvity Inc pays a 0.18% dividend while DigitalOcean Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold DigitalOcean Holdings Inc for 43 Days and Revvity Inc for 12 Days on average.

DOCNRVTY
Market Cap
$14.57B$16.98B
Volume
2,261,7861,456,900
Sector
TechnologyHealth
52-Week High
$181.29$157.36
52-Week Low
$37.30$82.26
Typical Hold Time
43 Days12 Days
Enterprise Value
$15.33B$19.30B
Dividend Yield
—0.18%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

DigitalOcean Holdings Inc

DigitalOcean trades at $127.28, down 2.89% today, with strong fundamentals including 29% revenue growth and consistent earnings beats. The company shows robust profitability with 57.22% gross margins and 23.27% net income margin, though valuation metrics remain elevated with P/E of 56.32. Recent AI-focused product launches and $725 million equipment financing facility support growth initiatives. Technical indicators show mixed signals with bullish oscillators but bearish moving averages, trading near key support at $126.

Outlook remains positive with analyst consensus target of $172.73 (35.7% upside) and 68% buy ratings. Key opportunities include AI-driven revenue growth and expanding cloud market share, while risks include high valuation, negative shareholder equity, and competitive pressure from larger cloud providers. The stock offers growth potential but requires careful monitoring of execution and market conditions.

Revvity Inc

RVTY trades at $153.60, up 0.2% today and near its 52-week high of $158.28 (Defense World, 2026-10-01). The stock shows a bullish technical trend with strong moving average signals and has beaten earnings estimates for three consecutive quarters. Recent developments include the launch of a CE-IVDR-certified T1D screening kit in Europe (Business Wire, 2026-09-24) and the acquisition of Human Cell Design to expand metabolic disease research tools (Business Wire, 2026-09-09).

The outlook is positive, supported by earnings momentum, strategic acquisitions, and analyst optimism. However, the stock trades at a premium valuation with a P/E of 73.15, and near-term risks include margin pressures in China and rich valuation limiting upside beyond consensus targets. Revenue stability but slight profit margin compression in 2026 warrants monitoring.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DOCN
100% Buy0% Sell
Avg holding period · 43 Days
RVTY

No sentiment data available yet.

Top news

Latest headlines on both assets

About DigitalOcean Holdings Inc

DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. The group has a business presence in North America, Europe, Asia and other countries.

Read more on DOCN →

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY →